Revelation Biosciences, Inc.

REVB · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$15-$0-$11-$12
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$3$1-$1$0
Other Non-Cash-$0-$8$0$0
Operating Cash Flow-$18-$7-$11-$11
Investing Activities
PP&E Inv.-$0$0$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$1
Other Inv. Act.$0$0$0-$1
Investing Cash Flow-$0$0$0-$0
Financing Activities
Debt Repay.$0$0-$1$0
Stock Issued$13$14$4$1
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$12$0
Financing Cash Flow$13$14$15$8
Forex Effect$0$0$0$0
Net Chg. in Cash-$5$7$4-$3
Supplemental Information
Beg. Cash$12$5$1$4
End Cash$6$12$5$1
Free Cash Flow-$18-$7-$11-$11